ErlySign, the Nagpur-based biotech startup developing India’s first salivary biomarker–based screening test for early-stage cancer detection, has announced the appointment of Akshay Churi as Vice President, Manufacturing.
The appointment comes as the company strengthens its leadership team to support the commercialisation and scale-up of its saliva-based early oral cancer detection technologies.
Churi brings over two decades of experience in medical technology, biosciences, and precision manufacturing, having previously served as Business Manager at Husky Technologies for South-East Asia and Middle East, at ZAHORANSKY, and previously has over 13 years of experience building and scaling precision manufacturing programmes, with strong expertise in mould development, project management, and strategic customer partnerships in the automotive sector.
At ErlySign, he will leverage this extensive experience to establish and scale the company’s manufacturing operations, including setting up a cleanroom facility, building and leading a high-performance team, securing regulatory approvals, and ensuring strong quality, compliance, and operational excellence standards while aligning plant performance and productivity with the company’s commercial growth objectives.
